Company Filing History:
Years Active: 2000-2006
Title: David Enshel: Innovator in Bimolecular Interactions
Introduction
David Enshel is a notable inventor based in Givatayim, Israel. He has made significant contributions to the field of bimolecular interactions, holding 2 patents that showcase his innovative approaches to vaccine development and protein structure elucidation.
Latest Patents
His latest patents include groundbreaking methods for the determination and control of bimolecular interactions. These methods utilize overlapping peptides for the discovery of discontinuous epitopes, which can be applied in vaccine development, drug design, and diagnostic purposes. Specifically, these techniques allow for the mapping of conformational epitopes using overlapping peptides, providing a more specific alternative to random phage libraries. Additionally, these methods can facilitate the development of DNA vaccines that leverage overlapping peptides across various expression systems. The conformational epitopes generated through these methods are valuable for preparing antibodies, creating components for diagnostic tools, and elucidating three-dimensional protein structures.
Career Highlights
David Enshel has worked with esteemed institutions such as Ramot University Authority for Applied Research and Industrial Development Limited and Ramot at Tel Aviv University Ltd. His work has significantly impacted the field of biomedical research, particularly in the areas of vaccine development and protein interaction studies.
Collaborations
One of his notable collaborators is Jonathan M. Gershoni, with whom he has worked on various projects related to bimolecular interactions.
Conclusion
David Enshel's innovative work in the field of bimolecular interactions has led to significant advancements in vaccine development and protein structure analysis. His contributions continue to influence the scientific community and pave the way for future research in this vital area.